Bill

Bill > S1386


NJ S1386

Requires health insurers to provide coverage for treatment of tick-borne diseases.


summary

Introduced
02/13/2020
In Committee
02/13/2020
Crossed Over
Passed
Dead
01/11/2022

Introduced Session

2020-2021 Regular Session

Bill Summary

This bill requires health insurers (health, hospital and medical service corporations, commercial individual and group health insurers, health maintenance organizations, health benefits plans issued pursuant to the New Jersey Individual Health Coverage and Small Employer Health Benefits Programs, the State Health Benefits Program, and the School Employees' Health Benefits Program) to provide coverage for expenses incurred in the treatment of a tick-borne disease. Treatment otherwise eligible for benefits pursuant to this bill may not be denied solely because such treatment may be characterized as experimental or investigational in nature or because the treatment requires the use of a prescription drug in an off-label manner.

AI Summary

This bill requires health insurers (including hospital, medical, and health service corporations, individual and group health insurers, health maintenance organizations, and state and school employee health benefits programs) to provide coverage for the treatment of tick-borne diseases, including long-term antibiotic therapy and ongoing testing. Treatment cannot be denied solely because it is characterized as experimental or investigational or involves the use of a prescription drug not approved by the FDA, if the drug is recognized as medically appropriate or recommended by a major peer-reviewed journal. The bill applies to policies delivered, issued, or renewed in New Jersey on or after the effective date, which is 90 days after enactment.

Committee Categories

Business and Industry

Sponsors (1)

Last Action

Introduced in the Senate, Referred to Senate Commerce Committee (on 02/13/2020)

bill text


bill summary

Loading...

bill summary

Loading...
Loading...